Drugs & medicalClass II

Aurobindo Pharma USA Inc. recalls Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC 13107-283-01, b) 500 tablets per bottle, NDC…

Discoloration: Dotted and yellow spots on tablets

Read the official notice →
Date
2024-05-15
Country
United States
Brand
Aurobindo Pharma
Product
Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC 13107-283-01, b) 500 tablets per bottle, NDC 13107-283-05, Rx…
Classification
Class II
Units
Nationwide in the USA
Category
Drugs & medical
Source
FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Aurobindo Pharma recalls

  1. 2024-12-25
  2. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc recalls Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East…

    CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebivolol above acceptable intake (AI) limit.

    FDA · DrugAurobindo Pharma USA IncNationwide in the USAOfficial notice →
  3. 2024-12-11
  4. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc recalls Cinacalcet Tablets, 60mg, packaged in: a) 30-count HDPE bottle (NDC 65862-832-30), b) 500-count HDPE bottle (NDC 65862-832-05), Rx Only,…

    cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit

    FDA · DrugAurobindo Pharma USA IncUSA NationwideOfficial notice →
  5. 2024-08-28
  6. US
    Drugs & medicalClass I

    Aurobindo Pharma USA Inc recalls Healthy Living Acetaminophen, Aspirin (NSAID) and Caffeine, tablets USP, 250 mg/250 mg/65 mg, 100-count bottles, Distributed by:…

    Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.

    FDA · DrugAurobindo Pharma USA IncNJ, NY & PAOfficial notice →
  7. 2023-09-27
  8. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc. recalls Rasagiline Tablets 0.5mg, 30-count bottle, Rx only, Mylan Pharmaceuticals Inc. Morgantown, WV 26505 U.S.A., NDC 0378-1270-93

    Failed dissolution specifications - results obtained were below spec average.

    FDA · DrugAurobindo Pharma USA Inc.USA nationwideOfficial notice →
  9. 2023-08-30
  10. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc. recalls Rufinamide Tablets, USP 400 mg, packaged in 120-count bottle, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279…

    cGMP deviations: Batch was released prior to approval.

    FDA · DrugAurobindo Pharma USA Inc.USA nationwideOfficial notice →
  11. 2023-05-31
  12. US
    Drugs & medicalClass II

    Aurobindo Pharma USA Inc. recalls Pain Reliever, Acetaminophen USP Caplets, 500 mg, 225-count bottles packaged in a cardboard carton, Distributed by: Walgreen Co., 200…

    Failed Impurities/Degradation Specifications: firm's investigation due to customer complaints for discoloration found that the product was out of specification for an impurity.

    FDA · DrugAurobindo Pharma USA Inc.The recalled product was distributed to one Retail Distributor (Walgreens) who…Official notice →
All 15 Aurobindo Pharma recalls →

Other drugs & medical recalls in the United States

  1. 2024-05-15
  2. US
    Drugs & medicalClass I

    Vyaire Medical, Inc. recalls Vyaire Medical GmbH, Vyaire Twin Tube sample line 240 cm, Model Number V-707327; The TwinTube sample line 240cm is used in the Vyntus CPX.…

    Potential of the nozzle separating during patient use.

    FDA · DeviceVyaire Medical, Inc.US nationwide distribution.Official notice →
  3. US
    Drugs & medicalClass I

    Tandem Diabetes Care, Inc. recalls t:connect mobile app used in conjunction with t:slim X2 insulin pump with Control-IQ technology

    During normal use, the mobile app version 2.7 may crash and be automatically relaunched by the iOS operating system. This cycle intermittently repeats, which leads to excessive Bluetooth communication that may result…

    FDA · DeviceTandem Diabetes Care, Inc.US nationwide distribution including Puerto Rico.Official notice →
  4. US
    Drugs & medicalClass II

    SUN PHARMACEUTICAL INDUSTRIES INC recalls Amphotericin B Liposome for Injection, 50mg vials, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ…

    Out of specification for assay

    FDA · DrugSUN PHARMACEUTICAL INDUSTRIES INCNationwide within the United StatesOfficial notice →
  5. US
  6. US
    Drugs & medicalClass II

    RemedyRepack Inc. recalls TraMADol HCl 50 mg Tablet, Packaged as (a) 30-count blister pack, NDC 70518-3824-00; (b) 90-count blister pack, NDC 70518-3824-02; (a)…

    Presence of Foreign Tablets: Manufacturer received a report from a Pharmacist who reported finding a tablet of baclofen in a bottle of 1000-count tramadol

    FDA · DrugRemedyRepack Inc.Nationwide in the USAOfficial notice →
  7. US
    Drugs & medicalClass II

    FDC Limited recalls Timolol Maleate Ophthalmic Solution, USP, 0.5%, packaged in a) 5mL bottles (NDC 64980-514-05), and b) 15 mL bottles (NDC 64980-514-15), Rx…

    Defective Container: yellow-colored spike from cap lodged in the nozzle. Firm received several complaints from customers.

    FDA · DrugFDC LimitedNew Jersey OnlyOfficial notice →
See all drugs & medical recalls →